[In vitro antibacterial activity of RU 51746 (sodium salt of cefpodoxime). Results of a multicenter study]. (Record no. 2201572)
[ view plain ]
| 000 -LEADER | |
|---|---|
| fixed length control field | 01419 a2200409 4500 |
| 005 - DATE AND TIME OF LATEST TRANSACTION | |
| control field | 20250511225828.0 |
| 008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION | |
| fixed length control field | 199008s 0 0 fre d |
| 022 ## - INTERNATIONAL STANDARD SERIAL NUMBER | |
| International Standard Serial Number | 0369-8114 |
| 040 ## - CATALOGING SOURCE | |
| Original cataloging agency | NLM |
| Language of cataloging | eng |
| Transcribing agency | NLM |
| 100 1# - MAIN ENTRY--PERSONAL NAME | |
| Personal name | Soussy, C J |
| 264 #0 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE | |
| Date of production, publication, distribution, manufacture, or copyright notice | 19900813 |
| 245 00 - TITLE STATEMENT | |
| Title | [In vitro antibacterial activity of RU 51746 (sodium salt of cefpodoxime). Results of a multicenter study]. |
| Medium | [electronic resource] |
| 260 ## - PUBLICATION, DISTRIBUTION, ETC. | |
| Name of publisher, distributor, etc. | Pathologie-biologie |
| Date of publication, distribution, etc. | May 1990 |
| 300 ## - PHYSICAL DESCRIPTION | |
| Extent | 336-42 p. |
| Other physical details | digital |
| 500 ## - GENERAL NOTE | |
| General note | Publication Type: Clinical Trial; English Abstract; Journal Article; Multicenter Study |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Anti-Bacterial Agents |
| General subdivision | pharmacology |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Ceftizoxime |
| General subdivision | analogs & derivatives |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Dose-Response Relationship, Drug |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Drug Resistance, Microbial |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Enterobacteriaceae |
| General subdivision | drug effects |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Haemophilus |
| General subdivision | drug effects |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | In Vitro Techniques |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Listeria |
| General subdivision | drug effects |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Multicenter Studies as Topic |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Neisseriaceae |
| General subdivision | drug effects |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Pseudomonas |
| General subdivision | drug effects |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Staphylococcus |
| General subdivision | drug effects |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Streptococcus |
| General subdivision | drug effects |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Cefpodoxime |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Le Van Thoi, J |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Kitzis, M D |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Chanal, C |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Mounier, M |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Derlot, E |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Vergnaud, M |
| 773 0# - HOST ITEM ENTRY | |
| Title | Pathologie-biologie |
| Related parts | vol. 38 |
| -- | no. 5 |
| -- | p. 336-42 |
No items available.